glp 1 out of pocket cost 68% GLP-1 Users Say Influenced Their Treatment Decisions The Rising Tide of GLP-1
Description
2027 to 2028 Commercial launch
doi: 10.1517/17460441.2014.942638 67 HorowitzMRaynerCKJonesKL
FDA-Approved Oral Options: Rybelsus is an FDA-approved oral semaglutide tablet approved for type 2 diabetes
Key takeaways Health insurance companies may stop covering GLP-1 medications for weight loss due to their rising costs and questions about their necessity
